[1] PATIL A, GOLDUST M, WOLLINA U. Herpes zoster: a review of clinical manifestations and management[J]. Viruses, 2022, 14(2):457-466. [2] COHEN E J. Commentary on herpes zoster and postherpetic neuralgia[J]. Clin Infect Dis, 2021, 73(9): e3218-e3219. [3] ZENG C, HUANG W, LI Y, et al. Roles of METTL3 in cancer: mechanisms and therapeutic targeting[J]. J Hematol Oncol, 2020, 13(1): 117-125. [4] PAN Z, ZHANG Q, LIU X, et al. Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner[J]. Pain, 2021, 162(7):1960-1976. [5] SOARES L C, AL-DALAHMAH O, HILLIS J, et al. Novel Galectin-3 roles in neurogenesis, inflammation and neurological diseases[J]. Cells, 2021, 10(11):1247-1256. [6] KOYANAGI M, IMAI S, MATSUMOTO M, et al. Pronociceptive roles of schwann cell-derived galectin-3 in taxane-induced peripheral neuropathy[J]. Cancer Res, 2021, 81(8):2207-2219. [7] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组. 带状疱疹中国专家共识[J]. 中华皮肤科杂志, 2018, 51(6): 403-408. [8] DUBINSKY R M, KABBANI H, EL-CHAMI Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2004, 63(6): 959-965. [9] YANG F, YU S, FAN B, et al. The epidemiology of herpes zoster and postherpetic neuralgia in China: results from a cross-sectional study[J]. Pain Ther, 2019, 8(2): 249-259. [10]皇甫佳欣, 沈德新. 带状疱疹后遗神经痛的中西医治疗进展[J]. 中国医药导报, 2020, 17(12): 65-68. [11]WARNER B E, GOINS W F, KRAMER P R, et al. A guide to preclinical models of zoster-associated pain and postherpetic neuralgia[J]. Curr Top Microbiol Immunol, 2022. 43(8): 189-221. [12]LI Y, GUO X, SUN L, et al. N6-methyl adenosine demethylase FTO contributes to neuropathic pain by stabilizing G9a expression in primary sensory neurons[J]. Adv Sci: Weinh, 2020, 7(13): 1902-1914. [13]DU K, ZHANG L, LEE T, et al. m6A RNA methylation controls neural development and is involved in human diseases[J]. Mol Neurobiol, 2019, 56(3): 1596-1606. [14]WANG W, LI Y, FAN J, et al. MiR-365-3p is a negative regulator in IL-17-mediated asthmatic inflammation[J]. Front Immunol, 2022, 13(9): 9537-9544. [15]ZHANG L, ZHAO X, WANG J, et al. METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing[J]. Cell Death Discov, 2022, 8(1): 80-87. [16]BURGUILLOS M A, SVENSSON M, SCHULTE T, et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation[J]. Cell Rep, 2015, 10(9): 1626-1638. [17]TAKASAKI I, TANIGUCHI K, KOMATSU F, et al. Contribution of spinal galectin-3 to acute herpetic allodynia in mice[J]. Pain, 2012, 153(3): 585-592. [18]LI J, GUO Y, CHEN Y Y, et al. miR-124-3p increases in high glucose induced osteocyte-derived exosomes and regulates galectin-3 expression: a possible mechanism in bone remodeling alteration in diabetic periodontitis[J]. FASEB J, 2020, 34(11):14234-14249. |